Caya
Alternative Name: SILCS Diaphragm
Description: A one-size-fits-most silicone barrier method.
Product Details
User: Female
Hormonal: No
Delivery Method: Barrier
Duration Type: Short-acting, Pericoital
Duration: Single use
Regimen: - single
- single
Inactive material: silicone
Multipurpose Preventive Technology (MPT): Yes
Status Details
Developer: PATH, CONRAD, SILCS, Inc., Kessel Marketing & Vertriebs GmbH
Project Phase: Limited Market Availability
Development Stage: SRA/WHO PQ Approved
Active Development: Yes
Status Details: - Received US FDA approval in 2014. Marketed in more than 20 countries. Available throughout Europe and in Canada.
- Received US FDA approval in 2014. Marketed in more than 20 countries. Available throughout Europe and in Canada.
Additional Information
References: PATH website: http://www.path.org/news/press-room/688/
Product website: https://www.caya.eu/en/
Beksinska M, Greener R, Smit J, Maphumulo B, Mphili N, Kilbourne-Brook M, Coffey PS. (2018). A randomized crossover study evaluating the use and acceptability of the SILCS diaphragm compared to vaginal applicators for vaginal gel delivery. AIDS Behavior. 22(1):127-132.
PATH website: http://www.path.org/news/press-room/688/
Product website: https://www.caya.eu/en/
Beksinska M, Greener R, Smit J, Maphumulo B, Mphili N, Kilbourne-Brook M, Coffey PS. (2018). A randomized crossover study evaluating the use and acceptability of the SILCS diaphragm compared to vaginal applicators for vaginal gel delivery. AIDS Behavior. 22(1):127-132.